EVALUATING THROMBOTIC RISK IN PATIENTS WITH COLORECTAL AND GASTRIC CANCER
DOI:
https://doi.org/10.22551/7n32yc79Keywords:
GASTRIC CANCER, COLORECTAL CANCER, THROMBOSISAbstract
We decided to study the computed tomography appearance and staging of gastric and colorectal cancers in relationship with vein thrombosis and pulmonary embolism because these tumors and their thrombotic complications are leading causes of morbidity and mortality in adult patients. Materials and methods: We retrospectively searched the databases of “Sf. Spiridon” County Clinical Emergency Hospital, Iasi, and we discovered 102 patients with gastric and colorectal cancer who underwent computed tomography (CT) with a 64 detectors Incisive Philips CT scan between January and December 2022. The study was focused on the CT appearance of the tumor (location, length and thickness, local invasion), lymphadenopathies, metastases, and the correlation between tumor characteristics and the tendency for vein thrombosis. Results: We studied 102 patients (77 with colorectal and 25 with gastric cancer), mean age: 68.85±13.13 years, and among them we discovered 19 (18.62%) cases with vein thrombosis. Cancer-associated thrombosis has a weak negative correlations tumor thickness and length, weak positive correlation with tumor extension outside the digestive wall, number of loco-regional lymphadenopathies, and metastases. Conclusions: We found a strong association between vein thrombosis and gastric and colorectal malignant tumors, there is a weak correlation with tumor extension outside the digestive wall, the number of loco-regional lymphadenopathies and the presence of metastases, so we cannot confidently predict thrombosis by studying these tumor characteristics.
References
1. Rees PA, Clouston HW, Duff S, Kirwan CC. Colorectal cancer and thrombosis. Int J Colorectal Dis 2018; 33(1): 105-108.
2. Schorling RM, Pfrepper C, Golombek T, et al. Evaluation of biomarkers for the prediction of venous thromboembolism in ambulatory cancer patients. Oncol Res Treat 2020; 43(9): 414-427.
3. Fernandes CJ, Morinaga LTK, Alves JL, et al. Cancer-associated thrombosis: the when, how and why. Eur Respir Rev 2019; 28(151):1-11.
4. Manafu EG, Filimon RM, Jari I, Petrariu FD, Manole A. Clinical epidemiological study on the inci-dence of Escherichia coli infections in the cancer patients admitted to surgery department II of the Iasi Regional Oncology Institute in 2013. Med Surg J-Rev Med Chir Soc Med Nat 2014; 118(3): 796-800.
5. Streiff MB, Holmstrom B, Angelini D, et al. NCCN guidelines insights: Cancer-associated venous thromboembolic disease, version 2.2018. J Natl Compr Cancer Netw 2018; 16(11): 1289-1303.
6. Lyman GH, Culakova E, Poniewierski MS, Kuderer NM. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res 2018; 164(Suppl 1): S112-S118.
7. Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO clinical practice guideline update. J Clin Oncol 2020; 38 (5): 496-520.
8. Volovat SR, Ursulescu-Lupascu CV, Gheorghe ML, et al. The landscape of nanovectors for modula-tion in cancer immunotherapy Pharmaceutics 2022; 14(2): 397.
9. Kakkos SK, Arnaoutoglou E, Tsolakis IA, et al. Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study. Int Angiol 2020; 39(2): 112-117.
10. Farge D, Frere C, Connors JM, et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol 2019; 20(10): e566-581.
11. Hong E, Castagnoli F, Gennaro N, et al. Locoregional CT Staging of Colon Cancer: Does a Learning Curve Exist? Abdom Radiol 2021; 46(2): 476-485.
12. Benard F, Barkun AN, Martel M, von Renteln D. Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations. World J Gas-troenterol 2018; 24(1): 124-138.
13. Yarema R, Оhorchak М, Hyrya P, et al. Gastric Cancer with Peritoneal Metastases: Efficiency of Standard Treatment Methods. World J Gastrointest Oncol 2020; 12(5): 569-581.
14. Saiz Martínez R, Dromain C, Vietti Violi N. Imaging of Gastric Carcinomatosis. J Clin Med 2021; 10 (22): 5294.
15. Rafaelsen S, Dam C, Vagn-Hansen C, et al. CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study. Current Oncology 2022; 29(2): 1069-1079.
16. Ji X, Bu Z, Yan Y, et al. The 8th Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System for Gastric Cancer is Superior to the 7th Edition: Results from a Chinese Mono-Institutional Study of 1,663 Patients. Gastric Cancer 2018; 21(4): 643-652.
17. Weiser MR. AJCC 8th Edition: Colorectal Cancer. Ann Surg Oncol 2018; 25: 1454-1455.
18. Ursaru M, Jari I, Popescu R, Negru D, Naum AG, Scripcariu V. Multifactorial Analysis of local and lymph node recurrences after conservative or radical surgery for stage 0-II breast cancer. Med Surg J-Rev Med Chir Soc Med Nat Iasi 2014; 118(4): 1062-1067.
19. Ursaru M, Jari I, Gheorghe L, Naum AG, Scripcariu V, Negru D. Bilateral breast cancer: diagnosis and prognosis Med Surg J-Rev Med Chir Soc Med Nat Iasi 2016; 120(2): 316-320.
20. Gheorghe L, Jari I, Naum AG. Neuroendocrine tumors: Choosing the appropriate imaging methods. Med Surg J-Rev Med Chir Soc Med Nat Iasi 2018; 122 (1): 16-22.
21. Savin ML, Mihai F, Gheorghe L, et al. Proposal of a Preoperative CT-Based Score to Predict the Risk of Clinically Relevant Pancreatic Fistula after Cephalic Pancreatoduodenectomy. Medicina Lithuania 2021; 57(7): 650.
22. Timpau AS, Miftode RS, Costache II, et al. An Overview of the Impact of Bacterial Infections and the Mortality Predictors in Patients with COVID-19 Admitted to a tertiary Center from Eastern Europe. Antibiot Chemother 2023; 12(1): 144.
Additional Files
Published
Issue
Section
License
Copyright (c) 2025 The Medical-Surgical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form
